Sunday Poster Session
Category: Biliary/Pancreas
Renato Beas, MD
Indiana University
Indianapolis, IN
Author | Study year | Study design | Country | Setting | Study Population | Female (%) | Mean age (SD) | Mode of Diagnosis of NAFLD | NAFLD (N) | Controls (N) | Mode of Diagnosis of NAFPD | NAFPD in Patients with NAFLD (N) | NAFPD in Controls (N) | NAFPD in patients with NAFLD (%) | NAFPD in Controls (%) (if reported) | OR | p-value |
Altinmakas | 2021 | Retrospective | Turkey | Outpatient clinic | Adult healthy renal transplantation donors | 49.40% | 46.3 ± 13.5 | Computed Tomography | 52 | 270 | Computed Tomography | 26 | 59 | 50.00% | 21.85% | 2.29 (1.92-3.96) | NR |
Berger | 2021 | Retrospective | Chile | Outpatient clinic | Healthy adults | 107 (53%) | 55 ± 12 | Computed Tomography | 55 | 148 | Computed Tomography | 19 | 42 | 34.54% | 28.37% | 1.22 (0.65-2.27) | 0.394 |
Bi | 2022 | Retrospective | China | Outpatient clinic | Adult volunteers for comprehensive health screening | 3636 (28.96%) | NR | Endoscopic ultrasound | 4732 | NA | Endoscopic ultrasound | 770 | NR | 16.27% | NR | NR | NR |
Chan | 2022 | Retrospective | China | Outpatient clinic | Adults invited by mail and telephone calls to undergo evaluation of NAFLD | 388 (61.5%) | 48 ± 11 years | Magnetic Resonance Spectroscopy (MRS) | 165 | NA | Magnetic Resonance Spectroscopy (MRS) | 67 | NA | 40.60% | NR | NR | NR |
Khoury | 2021 | Retrospective | Israel | Tertiaty Center | Patients who underwent EUS for non-acute hepatobiliary indication | 267 (46.92%) | NR | Endoscopic ultrasound | 298 | 271 | Endoscopic ultrasound | 66 | 12 | 22.14% | 4.42%% | 5.94 (3.16–11.16) | < 0.0001 |
Lesmana | 2015 | Cross-sectional study | Indonesia | Outpatient clinic | Adults undergoing health screening | 334 (31.68%) | 43.1 ± 12.19 | Abdominal Ultrasound | 437 | 519 | Abdominal Ultrasound | 232 | 83 | 53.08% | 15.90% | 5.195 (3.838-7.032) | < 0.001 |
Milovanovic | 2019 | Cross-sectional study | Serbia | Outpatient clinic | Adults with known NAFLD | 46 (32.16%) | NR | Abdominal Ultrasound | 143 | NA | Abdominal Ultrasound | 84 | NA | 58.74% | NR | NR | NR |
Okada | 2021 | Cross-sectional study | Japan | Outpatient clinic | Adults undergoing health screening | 45.70% | 59.5 ± 13.2 | Abdominal Ultrasound | 314 | NA | Abdominal Ultrasound | 246 | NA | 78.34% | NR | NR | NR |
Osman | 2022 | Cross-sectional study | Egypt | Outpatient clinic | Women with PCOS | 100% | NR | Abdominal Ultrasound | 77 | NA | Abdominal Ultrasound | 32 | NA | 41.55% | NR | NR | NR |
Sahin | 2022 | Retrospective | Turkey | Outpatient clinic | Adults with known NAFLD | 57.92% | 53.6 ± 9.7 | Abdominal Ultrasound | 183 | NA | Abdominal Ultrasound | 98 | NA | 53.55% | NR | NR | NR |
Sbeit | 2021 | Cross-sectional study | Israel | Outpatient clinic | Patients who underwent EUS for non-acute hepatobiliary indication | 46.92% | 62.9 ± 14.1 | Abdominal Ultrasound | 298 | 271 | Abdominal Ultrasound | 66 | 12 | 22.15% | 4.43% | 5.94 (3.16-11.16) | < 0.0001 |
Sbeit, W; Mahamid, M | 2021 | Case-Control Study | Israel | Outpatient clinic | Patients who underwent EUS for non-acute hepatobiliary indication | 46.23% | 61.2 ± 14.7 | Endoscopic ultrasound | 278 | 267 | Endoscopic ultrasound | 46 | 8 | 16.60% | 3% | 6.1 (2.86 - 13.04) | < 0.0001 |
Sepe | 2021 | Prospective | United States | Outpatient clinic | Patients who underwent EUS for non-acute hepatobiliary indication | 53.6 | 62.9 ± 13.9 | Endoscopic ultrasound | 52 | NA | Endoscopic ultrasound | 27 | NA | 51.95% | NR | NR | NR |
Sezgin | 2022 | Prospective | Turkey | Outpatient clinic | Adults attending the GI Clinic for a medical check up | 61.60% | 43.51 ± 16.66 | Abdominal Ultrasound | 67 | NA | Abdominal Ultrasound | 50 | NA | 74.62% | NR | NR | NR |
Ulasoglu | 2021 | Cross-sectional study | Turkey | Outpatient clinic | Dyspeptic patients referred for abdominal ultrasound | 63.7 | 52±15 | Abdominal Ultrasound | 219 | NA | Abdominal Ultrasound | 175 | NA | 79.90% | NR | NR | NR |
Uygun | 2015 | Case-Control Study | United States | Outpatient clinic | Adults with known NAFLD and healthy controls | 26 | 37.9 ± 1.3 | Abdominal Ultrasound | 84 | NA | Abdominal Ultrasound | 43 | NA | 51.10% | NR | NR | NR |
Wang | 2018 | Cross-sectional study | China | Outpatient clinic | Adults without pancreatic, liver or kidney disease | 52.9 | 45 ± 14 | Abdominal Ultrasound | 363 | NA | Abdominal Ultrasound | 38 | NA | 10.40% | NR | NR | NR |
Weng | 2018 | Cross-sectional study | China | Outpatient clinic | Adults undergoing health screening | 48.7 | NA | Abdominal Ultrasound | 1116 | NA | Abdominal Ultrasound | 301 | NA | 26.90% | NR | NR | NR |